Background Several treatments are available for treatment of early and very early-stage
Hepatocellular Carcinoma, also known as small Hepatocellular Carcinoma (SHCC) …

Background Several treatment strategies for early stage hepatocellular cancers (HCC) have
been evaluated in randomised controlled trials (RCTs). This network meta-analysis (NMA) …

BACKGROUND: A wide range of ablative and non-surgical therapies are available for
treating small hepatocellular carcinoma in patients with very early or early-stage disease …

Abstract Background & Aims Non‐surgical therapies are frequently used for patients with
early or very early hepatocellular carcinoma (HCC). The aim of this systematic review and …

There are several interventional therapies that improve the prognosis and increase the
survival rate of early-stage hepatocellular carcinoma (early-stage HCC), but it is uncertain …

Background: Major treatments for small hepatocellular carcinoma (SHCC) include
percutaneous ethanol injection (PEI), percutaneous acetic acid injection (PAI) …

Background A consensus on the most reliable staging system for hepatocellular carcinoma
(HCC) is still lacking but the most used is a revised Barcelona Clinic Liver Cancer (BCLC) …

Although hepatocellular carcinoma (HCC) is associated with a poor prognosis, management
of early-stage HCC is often successful with highly efficacious treatment modalities such as …

Simple Summary Cure is the goal of treatment in early primary liver cancer with surgical
resection and ablation therapy being the two most common modalities used. This real-world …

Background Hepatocellular carcinoma (primary liver cancer) is classified in many ways. The
Barcelona Clinic Liver Cancer (BCLC) group staging classifies the cancer based on patient's …